Immune Checkpoint Blockade Is Associated With Durable Responses in Pulmonary Sarcomatoid Carcinoma

Vineeth Sukrithan, Jason Sandler, Rasim Gucalp, Richard Gralla, Balázs Halmos

Research output: Contribution to journalArticle

6 Scopus citations
Original languageEnglish (US)
Pages (from-to)e242-e246
JournalClinical lung cancer
Volume20
Issue number3
DOIs
StatePublished - May 2019

Keywords

  • Checkpoint inhibitor
  • Immunotherapy
  • PD-L1
  • Pembrolizumab
  • Tumor mutational burden

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this